Skip to main content

Changes to the Repeat Prescriptions

From Wednesday 12th February 2025 we are asking you to order your medicine directly from the practice, rather than allowing your repeat prescriptions to be ordered on your behalf by your pharmacy. For more information, please read: Changes to repeat prescription requests

Drug safety alert from MHRA for GLP-1 and dual GIP/GLP-1 receptor agonists

You are receiving this message because you are currently taking a GLP-1 or dual GIP/GLP-1 receptor agonist which are Dulaglutide, Exenatide, Liraglutide, Lixisenatide, Semaglutide. The MHRA has issued a drug safety alert regarding a potential risk of pulmonary aspiration during general anesthesia or deep sedation. 

If you have a planned surgical procedure, please inform your healthcare team, including your anesthetist, about this prior to your surgical procedure.  This medicine slows the emptying of your stomach, increasing the risk that stomach contents (e.g. food and drink) could enter into your airways and lungs during surgery or procedures whilst you are under general anesthesia or deep sedation. This means that a modification to the pre-procedure instruction and anesthetic technique may be required . 

Please take your prescribed medicine(s) as usual and do not stop your treatment without first discussing this with your doctor.